Larvol Delta - WPD-Pharmaceuticals-Announces-Amended-Sublicense-Agreement-with-Moleculin-Biotech-for-WP1066-WP1122-and-Annamycin-Drug-Candidates

WP1066 - Moleculin, WPD Pharma

liposomal annamycin - WPD Pharma, Moleculin

WP1122 - Moleculin, CNS Pharma, WPD Pharma

https://finance.yahoo.com/news/wpd-pharmaceuticals-announces-amended-sublicense-113000942.html#:~:text=On%20March%2022%2C%202021%2C%20WPD,derived%20from%20these%20portfolios%20in

Mar 30, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next